Primavera Sound hails successful PRIMACOV trial
Organisers have hailed as a successful the PRIMACOV clinical trial, which took place at Barcelona’s Sala Apolo on Saturday (12 December) after a two-month delay.
Originally organised for October, PRIMACOV – organised by Primavera Sound in association with Hospital Germans Trias in Barcelona and the Fight AIDS and Infectious Diseases Foundation – welcomed 1,042 people to the 1,608-capacity venue for a clinical study designed to show whether rapid testing could hold the key to staging concerts without social distancing.
Everyone who was allowed into the show, which featured performances by local artists including Marta Salicrú, Unai Muguruza, Mujeres and Renaldo and Clara, had had to first test negative for Covid-19 using rapid antigen tests – the results of which were available in 15 minutes – as well as traditional PCR tests.
“The objective of this study is to validate these kind of tests … to be able to carry out events without social distancing”
“That was, precisely, the objective of this study: to validate these kind of tests as an extremely useful tool to be able to carry out any type of event, whether musical or not, without social distancing,” explain the PRIMACOV team.
The show followed a similar trial in Germany, dubbed Restart-19, which found that live shows could take place safely under “specific conditions during a pandemic”. Several ‘Back to Live’ pilot events will also take place in the Netherlands, with the government’s backing, in January.
The results of the PRIMACOV trial will be released in mid-January, according to Primavera Sound, although the festival warns that the results will only be completely accurate if all 1,042 attendees have a second PCR test, on Sunday 20 December.
PRIMACOV is part of Primavera’s Back on Track initiative, which is supported by Live Nation, Universal Music Group, Ticketmaster, Sony Music, promoter Last Tour and collection society SGAE, among others.
Get more stories like this in your inbox by signing up for IQ Index, IQ’s free email digest of essential live music industry news.